Devyser launches the first IVDR compliant NGS assay for thalassemia and sickle cell disease testing
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
News | September 18, 2019
Devyser is now searching for 2 new research scientists and a senior scientist to join our research and development team! Do you know a stellar researcher with experience in NGS, qPCR and diagnostics? This could be the role for you!
Did you know that Devyser is one of Swedens best workplaces? With a diverse international team and a welcoming environment there’s more to Devyser than the meaningful work you do on a daily basis.
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
Read More
Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announces that it has...
Read More
Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA...
Read More
Devyser is proud to announce that the company has been awarded a tender by Oslo University Hospital...
Read More